Trending Now
- “I will soon make an announcement regarding a statewide tour across Tamil Nadu.” – O. Panneerselvam.
- Vatsala, Asia’s oldest elephant, has passed away at Panna Tiger Reserve; social activists mourn the death of this elephant, which lived for over 100 years.
- “The U.S. Govt earned ₹8 lakh crore this year through increased tariffs on foreign goods.” – U.S President Donald Trump.
- World No.1 Aryna Sabalenka has advanced to the semifinals in the Women’s Singles category at Wimbledon Tennis.
Businesswire
Taro Announces Completion of $250 Million Share Repurchase Program
January 16, 2019
Taro Pharmaceutical Industries Ltd. (NYSE: TARO) announced that it has completed its $250 million share repurchase program. The company bought back 2,493,378 of its ordinary shares in open market transactions at an average price of $100.28 per share. The repurchase program was announced by the company on November 23, 2016, and was completed on January 11, 2019.
About Taro
Taro Pharmaceutical Industries Ltd. is a multinational, science-based pharmaceutical company, dedicated to meeting the needs of its customers through the discovery, development, manufacturing and marketing of the highest quality healthcare products. For further information on Taro Pharmaceutical Industries Ltd., please visit the Company’s website at www.taro.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190115005928/en/
Source: Businesswire
